Atherosclerosis and atherothrombosis, the major contributors to cardiovascular diseases
(CVDs), represent the leading cause of death worldwide. Current pharmacological therapies …

Smart drug delivery systems represent state-of-the-art approaches for targeted therapy of life-
threatening diseases such as cancer and cardiovascular diseases. Stimuli-responsive on …

Stroke is responsible for 11% of all deaths worldwide, the majority of which are caused by
ischemic strokes, thus making the need to urgently find safe and effective therapies. Today …

Antithrombosis therapy is confronted with short half-lives of thrombolytic agents, limited
therapeutic effects, and bleeding complications. Drug delivery systems of thrombolytic …

The development of thrombolytic drug carriers capable of thrombus-targeting, prolonged
circulation time, intelligent responsive release, and the ability to inhibit thrombotic …

Thrombosis seriously endangers human health with high incidence and mortality worldwide,
and the clinical treatment is challenged by low bioavailability of thrombolytic agents, high …

Practical implementation of minimally invasive biomedical applications has been a long-
sought goal for microrobots. In this field, most previous studies only demonstrate microrobots …

Iron oxides are multifunctional materials that have been extensively explored for many
applications, including in novel biomedical applications. However, boosting their ability for …

Nowadays, cardiovascular and cerebrovascular diseases caused by venous
thromboembolism become main causes of mortality around the world. The current …

Vascular diseases (VDs) pose the leading threat worldwide due to high morbidity and
mortality. The detection of VDs is commonly dependent on individual signs, which limits the …